The global women's health market size reached US$ 39.32 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 51.65 Billion by 2028, exhibiting a growth rate (CAGR) of 4.33% during 2023-2028. The growing population of elderly women, and the specific health needs associated with aging, changing societal norms and attitudes towards women's health, and the rising funding for better access to healthcare services are some of the major factors propelling the market.
|Market Size in 2022
||US$ 39.32 Billion
|Market Forecast in 2028
||US$ 51.65 Billion
|Market Growth Rate 2023-2028
Women's health refers to the branch of medicine that focuses on the treatment and diagnosis of diseases and conditions that affect a woman's physical and emotional well-being. It encompasses a broad range of specialties and focus areas, such as reproductive health, maternal health, mental health, and non-communicable diseases, which can all significantly impact women. It is vital not only for the individual well-being of women, but it also has wider societal implications relating to economic productivity, family stability, and public health outcomes. Furthermore, it's important to note that these issues are influenced by biological factors as well as gender-related differences in societal norms, lifestyle choices, and access to healthcare. Thus, a comprehensive approach to women's health necessitates understanding and addressing these multifaceted dimensions.
The aging female population is a key driver of the women's health market. As women age, they face a specific set of health challenges including menopause, osteoporosis, heart disease, and certain types of cancer. This increasing population of elderly women globally, and the specific health needs associated with aging, create a robust demand for services and products. Along with this, changing societal norms and attitudes towards women's health have also acted as a significant driver in this industry. Therefore, the growing recognition of rights and the need for gender-specific healthcare is positively influencing the market. In addition, the rise in healthcare spending across the globe also contributes significantly to the growth of the women's health market. With higher income levels, individuals and families are more inclined to invest in preventive and curative healthcare. Governments, too, are dedicating larger portions of their budgets towards healthcare. This accelerated funding allows for better access to healthcare services and promotes advancements in women's healthcare research and product development.
Women's Health Market Trends/Drivers:
Increased Awareness and Government Initiatives
Over the past few years, governments across the globe, non-profit organizations, and international agencies have played an instrumental role in heightening awareness about women's health issues. This has been primarily achieved through campaigns, policy changes, and funding for research and services. These initiatives have fostered an environment where health matters are gaining global attention, leading to increased demand for women's health products and services. Moreover, these government initiatives often include provisions for health screenings, diagnostic tests, and preventive measures, which further drive the growth of the industry. Various government acts, for instance, make preventative services for a mandatory health insurance provision, amplifying the demand for such services.
Continuous Advancements in Technology
The rapid advancement in technology has significantly impacted the women's health industry. Along with this, diagnostic tools and therapies have evolved and improved, which have led to better disease detection, more effective treatments, and increased survival rates. Digital health technologies, such as telehealth, mobile apps, and wearable devices are now assisting women in tracking and managing their health more efficiently. Advanced technologies, including artificial intelligence and machine learning, are also being employed in the diagnosis and treatment of various related issues. These technological advancements ensure more effective and personalized healthcare solutions for women but also stimulate the market's growth by creating new opportunities and demands.
Rising Incidences of Chronic Diseases
An increasing incidence of chronic diseases among women, such as cancer (specifically breast and cervical cancer), cardiovascular diseases, diabetes, and osteoporosis, is driving the need for these services. According to global health organizations, non-communicable diseases, notably cancer, and cardiovascular diseases, are responsible for the majority of deaths among women across the globe. In confluence with this, this alarming rise in chronic conditions among women necessitates timely detection, effective treatment options, and increased preventive care, which are the major propellers for the women's health industry. Also, reproductive health remains a significant aspect of the market. The industry is witnessing a growing emphasis on access to family planning services, prenatal care, and safe childbirth practices to reduce maternal and infant mortality rates, further impacting the market.
Women's Health Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global women's health market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on age group, application and distribution channel.
Breakup by Age Group Type:
- 50 Years and Above
- Postmenopausal Osteoporosis
- Endometriosis and Uterine Fibroids
50 Years and Above dominate the market
The report has provided a detailed breakup and analysis of the market based on the age group. This includes 50 years and above (postmenopausal osteoporosis, endometriosis and uterine fibroids, and menopause), and others. According to the report, 50 years and above represented the largest segment.
The 50 years and above age group in the industry has witnessed significant market drivers over the past decades. One of the primary factors contributing to this trend is the global demographic shift towards an aging population, leading to an increased number of women entering this age bracket. Additionally, advancements in healthcare technology and increased access to medical services have enabled better diagnoses and treatments for age-related health conditions in women. In addition, the growing awareness among this demographic regarding preventive healthcare measures and wellness has influenced the demand for specialized products and services catering to their unique needs. As women in this age group seek to maintain their health and quality of life, there is an escalating demand for menopause-related treatments, bone health supplements, and preventive screenings. This market segment's potential for growth is further bolstered by the expanding focus on research, allowing the industry to offer targeted and evidence-based solutions.
Breakup by Application:
Contraceptives dominate the market
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes contraceptives, osteoporosis, menopause, infertility, and others. According to the report, contraceptives represented the largest segment.
The industry has been significantly influenced by the increasing global awareness of family planning and reproductive health. Governments, organizations, and healthcare providers are emphasizing the importance of safe and effective contraceptive methods to empower women to make informed choices about their reproductive health. Additionally, advancements in medical technology have led to the development of a wide range of contraceptive options, offering women more choices and personalized solutions to suit their preferences and needs. In confluence with this, the shifting societal attitudes towards women's rights and gender equality have resulted in greater access to contraceptive products and services, enabling women to take control of their reproductive decisions. Furthermore, the growing prevalence of sexually transmitted infections has reinforced the importance of using contraceptives as a means of protection.
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Hospital pharmacies dominate the market
The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.
The hospital pharmacies distribution channel in the industry is experiencing significant market drivers that shape its growth and development. One of the key factors contributing to the prominence of this distribution channel is the rising demand for specialized women's health medications and treatments within hospital settings. Hospitals serve as essential centers for comprehensive medical care, making them an ideal platform to provide a wide range of women's health products, including contraceptives, hormone therapies, fertility medications, and prenatal supplements. Additionally, the increasing prevalence of chronic conditions, such as gynecological disorders and menopause-related symptoms, has led to a growing need for prompt access to medications and treatments, which hospital pharmacies can efficiently cater to. Furthermore, regulatory initiatives and healthcare policies that encourage hospitals to maintain well-stocked pharmacies with a focus on women's health contribute to the expansion of this distribution channel.
Breakup by Region:
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The industry in North America is influenced by the region's aging population. It contributes to an increased demand for women's health services and products catering to menopausal and post-menopausal women. Additionally, the growing awareness and emphasis on preventive healthcare measures among women drive the market for screenings, wellness programs, and specialized treatments. In addition, advancements in medical research and technology facilitate the development of innovative solutions, encouraging investment and competition in the industry.
Moreover, favorable healthcare policies and insurance coverage for women's health services bolster market growth. Apart from this, shifting cultural attitudes towards women's empowerment and gender equality enhances access to comprehensive healthcare, including family planning and contraceptive options. Furthermore, strategic marketing efforts and educational campaigns by industry players to promote health and wellness further fuel market expansion.
The global women's health market is experiencing significant growth due to the growing investments in research and development to create new and improved women's health products, including contraceptives, fertility treatments, hormone therapies, prenatal vitamins, and other related medications. Along with this, companies are promoting their women's health products and services through marketing campaigns to grow awareness among healthcare providers and consumers. These campaigns often focus on promoting the benefits and efficacy of their offerings. Numerous companies are forming partnerships with healthcare providers, clinics, hospitals, and other organizations to expand their market reach and enhance distribution channels, impacting the market. Moreover, the introduction of educational programs for healthcare professionals to ensure proper understanding and usage of their products is contributing to the market.
The report has provided a comprehensive analysis of the competitive landscape in the global women's health market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Abbott Laboratories
- AbbVie Inc.
- Agile Therapeutics Inc.
- Amgen Inc.
- Bayer AG
- Hoffmann-La Roche AG
- Ferring Pharmaceuticals
- FUJIFILM Holdings Corporation
- Hologic Inc.
- Lupin Limited
- Novo Nordisk A/S
- Pfizer Inc.
- In June 2023, AbbVie Inc. revealed the names of the 20 amazing women business owners who will receive grants and mentoring from the IFundWomen and BOTOX® Cosmetic award programme.
- In October 2021, Abbott Laboratories stated that it has signed a three-year contract to serve as the Real Madrid Football Club's Global Health Sciences and Nutrition Partner and Global Partner of the Real Madrid Foundation, whose mission is to spread the ideals of sport to adolescents all over the world. In addition to providing nutritional assistance for the inaugural men's and women's Academy teams as well as new product development, the alliance will also benefit at-risk youngsters in 80 countries via educational, sporting, and social welfare initiatives.
- In June 2023, Agile Therapeutics Inc. stated that MMCAP Infuse Members would have access to the Twirla (levonorgestrel and ethinyl estradiol) transdermal system. The business anticipates that this improved supply will have a favorable effect on demand growth and factory sales in the non-retail channel, which climbed 20% and 15%, respectively, from the fourth quarter of 2022 to the first quarter of 2023.
Women's Health Market Report Scope:
|Base Year of the Analysis
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- Age Group
- Distribution Channel
|Age Group Types Covered
- 50 Years and Above: Postmenopausal Osteoporosis, Endometriosis and Uterine Fibroids, Menopause
||Contraceptives, Osteoporosis, Menopause, Infertility, Others
|Distribution Channels Covered
||Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Abbott Laboratories, AbbVie Inc., Agile Therapeutics Inc., Amgen Inc., Bayer AG, Hoffmann-La Roche AG, Ferring Pharmaceuticals, FUJIFILM Holdings Corporation, Hologic Inc., Lupin Limited, Novo Nordisk A/S, Pfizer Inc., etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global women's health market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global women's health market?
- What is the impact of each driver, restraint, and opportunity on the global women's health market?
- What are the key regional markets?
- Which countries represent the most attractive women's health market?
- What is the breakup of the market based on the age group?
- Which is the most attractive age group in the women's health market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the women's health market?
- What is the breakup of the market based on the distribution channel?
- Which is the most attractive distribution channel in the women's health market?
- What is the competitive structure of the global women's health market?
- Who are the key players/companies in the global women's health market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the women's health market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global women's health market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the women's health industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.